|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization | |||||
| Change in fair value of deferred compensation plan | |||||
| Equity-based compensation | |||||
| Equity in (earnings) loss in unconsolidated entities | |||||
| Deferred tax expense (benefit) | |||||
| Impairment | |||||
| (Gain) loss on disposal of assets | |||||
| Total (Gain) loss on disposal of assets | |||||
| Amortization of other assets | |||||
| Amortization of loan costs | |||||
| Realized loss on investment | |||||
| Other (gain) loss | |||||
| Changes in operating assets and liabilities, exclusive of the effect of acquisitions: | |||||
| Accounts receivable | |||||
| Due from affiliates | |||||
| Due from related parties | |||||
| Ashford Trust | |||||
| Braemar | |||||
| Inventories | |||||
| Prepaid expenses and other | |||||
| Investment in unconsolidated entities | |||||
| Operating lease right-of-use assets | |||||
| Other assets | |||||
| Accounts payable and accrued expenses | |||||
| Due to affiliates | |||||
| Due to related party | |||||
| Claims liabilities and other | |||||
| Operating lease liabilities | |||||
| Deferred income | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash Flows from Investing Activities | |||||
| Additions to property and equipment | |||||
| Proceeds from sale of property and equipment, net | |||||
| Additional purchase price paid for Remington working capital adjustment | |||||
| Restricted cash acquired in asset acquisition of RHC | |||||
| RHC | |||||
| Acquisitions, net of cash acquired | |||||
| Alii Nui Maui | |||||
| Chesapeake | |||||
| TSGP L.P. | |||||
| Total acquisitions, net of cash acquired | |||||
| Investments | |||||
| Total investments | |||||
| Cash held by Marietta upon disposition | |||||
| Asset acquisition | |||||
| Acquisition of noncontrolling interest in consolidated subsidiaries | |||||
| Purchase of common stock of related parties | |||||
| Proceeds from sale of equity method investment | |||||
| Proceeds from note receivable | |||||
| Issuance of notes receivable | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash Flows from Financing Activities | |||||
| Proceeds from issuance of common stock | |||||
| Repurchase of common stock | |||||
| Payments for dividends on preferred stock | |||||
| Payments on revolving credit facilities | |||||
| Borrowings on revolving credit facilities | |||||
| Proceeds from notes payable | |||||
| Payments on notes payable | |||||
| Payments on finance lease liabilities | |||||
| Payments of loan costs | |||||
| Purchase of treasury stock | |||||
| Repurchase of restricted common stock upon vesting | |||||
| Employee advances | |||||
| Contributions from noncontrolling interests, net of issuance costs | |||||
| Distributions to noncontrolling interests | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of foreign exchange rate changes on cash and cash equivalents | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Restricted cash at end of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental Cash Flow Information | |||||
| Interest paid | |||||
| Income taxes paid (refunded), net | |||||
| Supplemental Disclosure of Non-Cash Investing and Financing Activities | |||||
| Acquisition of Alii Nui through issuance of RED Units | |||||
| Total acquisition of Alii Nui through issuance of RED Units | |||||
| Distribution from deferred compensation plan | |||||
| Capital expenditures accrued but not paid | |||||
| Finance lease additions | |||||
| Acquisition of noncontrolling interest in consolidated entities with notes payable and common stock | |||||
| Total acquisition of noncontrolling interest in consolidated entities with notes payable and common stock | |||||
| Settlement of contingent consideration liability | |||||
| Supplemental Disclosure of Cash, Cash Equivalents and Restricted Cash | |||||
| Cash and cash equivalents at beginning of period | |||||
| Restricted cash at beginning of period | |||||
Loading...